Publicaciones
-
González-Anleo C, Girona M, Casaldàliga A, Bobillo-Perez S, Fresán-Ruiz E, Solé-Ribalta A, Velasco E, Manuel Monsonis Cabedo, Urrea M and Jordán-García I.
Risk factors for multidrug-resistant bacteria in critically ill children and MDR score development.
EUROPEAN JOURNAL OF PEDIATRICS . 183(12): 5255-5265.
-
Luque S, Mendoza-Palomar N, Aguilera-Alonso D, Garrido B, Miarons M, Piqueras AI, Tévar E, Velasco E and Fernàndez-Polo A.
[Translated article] Therapeutic Drug Monitoring of antibiotic and antifungical drugs in paediatric and newborn patients. Consensus Guidelines of the Spanish Society of Hospital Pharmacy (SEFH) and the Spanish Society of Paediatric Infectious Diseases (SEIP).
FARMACIA HOSPITALARIA . 48(5): .
-
Luque S, Mendoza-Palomar N, Aguilera-Alonso D, Garrido B, Miarons M, Piqueras AI, Tévar E, Velasco E and Fernàndez-Polo A.
Therapeutic Drug Monitoring of antibiotic and antifungical drugs in paediatric and newborn patients. Consensus Guidelines of the Spanish Society of Hospital Pharmacy (SEFH) and the Spanish Society of Paediatric Infectious Diseases (SEIP).
anales de pediatria . 101(3): 190-207.
-
Gamell Fullà A, Velasco E, López-Ramos MG, Rios-Barnés M, Simó-Nebot S, Fumadó V, Noguera-Julián A and Fortuny-Guasch C.
Off-label use of dalbavancin in children: a case series
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . 79(8): 2062-2067.
-
Rios-Barnés M, Velasco E, Fortuny C, Benavides M, Baquero-Artigao F, Muga O, Del Valle R, Frick MA, Bringué X, Herrero S, Vilas J, Alonso-Ojembarrena A, Castells-Vilella L, Rojo P, Blázquez-Gamero D, Esteva-Afonso C, Sánchez E, Alarcon A and Noguera-Julián A.
Renal Function Impairment in Children With Congenital Cytomegalovirus Infection: A Cross-sectional Study.
PEDIATRIC INFECTIOUS DISEASE JOURNAL . 43(3): 257-262.
-
Comes A, Villaronga M, Velasco E, Esteban-Torne E, Pertierra-Cortada A and Noguera-Julián A.
Renal fungus balls in neonates and very young infants treated with local amphotericin B deoxycholate: Two case reports and review of the literature.
enfermedades infecciosas y microbiologia clinica (english ed.) . 42(1): 38-41. Nº de citas: 1
-
Guarch-Ibanez, B, Fernandez-Polo, A, Hernandez, S, Velasco E, Gimenez, M, Sala-Castellvi, P, Pineda, V, Melendo, S and VINCat Pediatric Proa Group.
Assessment of the Plans to Optimize Antimicrobial Use in the Pediatric Population in Catalan Hospitals: The VINCat Pediatric PROA SHARP Survey
ANTIBIOTICS-BASEL . 12(2): . Nº de citas: 1
-
López-Ramos MG, Vinent-Genestar J, Aarnoutse R, Colbers A, Velasco E, Martorell-Sampol L, Falcón-Neyra L, Neth O, Prieto L, Guillén S, Baquero-Artigao F, Méndez-Echevarría A, Gómez-Pastrana D, Jiménez AB, Lahoz R, Ramos-Amador JT, Soriano-Arandes A, Santiago B, Rosa Farré Riba, Fortuny-Guasch C, Soy D and Noguera-Julián A.
Adequacy of the 10 mg/kg Daily Dose of Antituberculosis Drug Isoniazid in Infants under 6 Months of Age
ANTIBIOTICS-BASEL . 12(2): .
-
Velasco E, Batllori-Tragant M, Manuel Monsonis Cabedo, Valls-Lafon A, Rios-Barnés M, Simó-Nebot S, Gamell Fullà A, Fortuny-Guasch C, Tebruegge M and Noguera-Julián A.
Host, technical, and environmental factors affecting QuantiFERON-TB Gold In-Tube performance in children below 5 years of age
SCIENTIFIC REPORTS . 12(1): 19908-19908. Nº de citas: 2
-
Simó-Nebot S, López-Ramos MG, Velasco E, Jordán-García I, Fortuny-Guasch C and Noguera-Julián A.
Impact and quality of antimicrobial use in a referral pediatric intensive care unit.
enfermedades infecciosas y microbiologia clinica (english ed.) . 40(2): 78-81.